Imaging Analyses of Bone Tumors

被引:9
作者
Errani, Costantino [1 ]
Tsukamoto, Shinji [2 ]
Mavrogenis, Andreas F. [3 ]
机构
[1] IRCCS Ist Ortoped Rizzoli, Dept Orthopaed Oncol, Bologna, Italy
[2] Nara Med Univ, Dept Orthopaed Surg, Nara, Japan
[3] Natl & Kapodistrian Univ Athens, Sch Med, Dept Orthopaed 1, Athens, Greece
关键词
POSITRON-EMISSION-TOMOGRAPHY; PROTON MR SPECTROSCOPY; EWING SARCOMA; MUSCULOSKELETAL NEOPLASMS; DIFFERENTIAL-DIAGNOSIS; CHEMOTHERAPY RESPONSE; FDG-PET; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE EVALUATION; SUBACUTE OSTEOMYELITIS;
D O I
10.2106/JBJS.RVW.19.00077
中图分类号
R61 [外科手术学];
学科分类号
摘要
>> Despite the evolution in imaging, especially the introduction of advanced imaging technologies, radiographs still are the key for the initial assessment of a bone tumor. Important aspects to be considered in radiographs are the location, shape and size or volume, margins, periosteal reaction, and internal mineralization of the tumor's matrix; careful evaluation of these may provide for accurate diagnosis in >80% of cases. >> Computed tomography and magnetic resonance imaging are often diagnostic for lesions with typical findings such as the nidus of osteoid osteoma and bone destruction such as in Ewing sarcoma and lymphoma that may be difficult to detect with radiographs; they may also be used for surgical planning. Magnetic resonance imaging accurately determines the intraosseous extent and articular and vascular involvement by the tumor. >> This article summarizes the diagnostic accuracy of imaging analyses in bone tumors and emphasizes the specific radiographic findings for optimal radiographic diagnosis of the patients with these tumors.
引用
收藏
页数:11
相关论文
共 99 条
[91]   Musculoskeletal tumors: Does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? [J].
van der Woude, HJ ;
Verstraete, KL ;
Hogendoorn, PCW ;
Taminiau, AHM ;
Hermans, J ;
Bloem, JL .
RADIOLOGY, 1998, 208 (03) :821-828
[92]   Soft-tissue tumors: Value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy [J].
van Rijswijk, CSP ;
Geirnaerdt, MJA ;
Hogendoorn, PCW ;
Taminiau, AHM ;
van Coevorden, F ;
Zwinderman, AH ;
Pope, TL ;
Bloem, JL .
RADIOLOGY, 2004, 233 (02) :493-502
[93]   Magnetic resonance imaging of the bone marrow in hematological malignancies [J].
Vande Berg, BC ;
Lecouvet, FE ;
Michaux, L ;
Ferrant, A ;
Maldague, B ;
Malghem, J .
EUROPEAN RADIOLOGY, 1998, 8 (08) :1335-+
[94]   OSTEOSARCOMA AND EWINGS-SARCOMA AFTER NEOADJUVANT CHEMOTHERAPY - VALUE OF DYNAMIC MR-IMAGING IN DETECTING VIABLE TUMOR BEFORE SURGERY [J].
VANDERWOUDE, HJ ;
BLOEM, JL ;
VERSTRAETE, KL ;
TAMINIAU, AHM ;
NOOY, MA ;
HOGENDOORN, PCW .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 165 (03) :593-598
[95]   BENIGN AND MALIGNANT MUSCULOSKELETAL LESIONS - DYNAMIC CONTRAST-ENHANCED MR-IMAGING - PARAMETRIC FIRST-PASS IMAGES DEPICT TISSUE VASCULARIZATION AND PERFUSION [J].
VERSTRAETE, KL ;
DEDEENE, Y ;
ROELS, H ;
DIERICK, A ;
UYTTENDAELE, D ;
KUNNEN, M .
RADIOLOGY, 1994, 192 (03) :835-843
[96]   MRI contrast agents: Classification and application (Review) [J].
Xiao, Yu-Dong ;
Paudel, Ramchandra ;
Liu, Jun ;
Ma, Cong ;
Zhang, Zi-Shu ;
Zhou, Shun-Ke .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (05) :1319-1326
[97]   Characterization of Chondroblastic Osteosarcoma: Gadolinium-Enhanced Versus Diffusion-Weighted MR Imaging [J].
Yakushiji, Toshitake ;
Oka, Kiyoshi ;
Sato, Hiro ;
Yorimitsu, Shigeta ;
Fujimoto, Toru ;
Yamashita, Yasuyuki ;
Mizuta, Hiroshi .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 29 (04) :895-900
[98]   The natural history of disappearing bone tumours and tumour-like conditions [J].
Yanagawa, T ;
Watanabe, H ;
Shinozaki, T ;
Ahmed, AR ;
Shirakura, K ;
Takagishi, K .
CLINICAL RADIOLOGY, 2001, 56 (11) :877-886
[99]   A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker Development [J].
Zhao, Binsheng ;
Oxnard, Geoffrey R. ;
Moskowitz, Chaya S. ;
Kris, Mark G. ;
Pao, William ;
Guo, Pingzhen ;
Rusch, Valerie M. ;
Ladanyi, Marc ;
Rizvi, Naiyer A. ;
Schwartz, Lawrence H. .
CLINICAL CANCER RESEARCH, 2010, 16 (18) :4647-4653